4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000950170-24-101993
CEO & President sold 2,757 shares at $1.35 ($3,722)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shukla Sath CEO & President | 2024-08-27 | Sale | −2,757 | $1.35 | $3,722 | 1,140,809 | D |
| Open-market sales · 2,757 sh · avg $1.35 · $3,722 | |||||||
Loading xslF345X05/ownership.xml…